top of page
ACAD Gets approval of Trofinetide for Rett Syndrome
Congrats to $ACAD, its investors, & Rett Syndrome patients on approval of DAYBUE (Trofinetide) for the treatment of Rett Syndrome • Rare genetic disease • 1st approved drug • Supported by Phase 3 Lavender trial data. • No Black Box warning on label • Nice stock runup to approval ~33% • BPIQ Big Mover event • ACAD gets FDA rare pediatric disease voucher • Value ~$100M Competitors from BPIQ Company Screener: $TSHA $AVXL $JAZZ Read more about upcoming PDUFAs https://www.bpiq.com
Mar 11, 2023
March 2023 Big Mover™ Stocks and Movers to Watch Report
First posted 2/24/23; updated 4/3/23
Feb 23, 2023
Biotech PDUFAs to Watch March 2023 - CDTX, BMRN
Originally posted 2/9/2023; last updated 3/29/23
Feb 9, 2023
Biopharma Pulse - 6/20-6/24 Week in Review
As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 24, 2022
Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 2022
Free Biopharma Daily Stock Updates - 06/21/22
$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...
Jun 21, 2022
Biopharma Pulse - 6/13-6/17 Week in Review
As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 17, 2022
Biopharma Daily Stock Updates - 06/15/22
$XBI $65.68 | +3.56% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #BNTX +2.4% & $PFE Pfizer and...
Jun 15, 2022
Free Biopharma Daily Stock Updates - 06/15/22
$XBI $65.68 | +3.56% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #BNTX +2.4% & $PFE Pfizer and...
Jun 15, 2022
Q1 2022 Orbimed Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 19, 2022
Q1 2022 Perceptive Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 19, 2022
Q1 2022 Baker bros Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 18, 2022
Q1 2022 EcoR1 Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 16, 2022
J.P. Morgan Healthcare Conference
The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...
Dec 31, 2021
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page